Articles published by Ipsen Pharma
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
September 19, 2025
From Ipsen Pharma
Via GlobeNewswire
Ipsen announces changes to its Executive Committee
July 23, 2025
From Ipsen Pharma
Via GlobeNewswire

From Ipsen Pharma
Via GlobeNewswire
From Ipsen Pharma
Via GlobeNewswire







Ipsen receives its second Shingo Prize for operational excellence
October 14, 2024
From Ipsen Pharma
Via GlobeNewswire










Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.